JRC Publications Repository

	Advanced Search
	Home

Browse
	Communities & Collections
	Publication Year
	Author
	Title
	JRC Publication N°
	Publication Type
	eBooks

JRC Publications Repository >

Browsing by Author BRUCHERTSEIFER Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:

Showing results 38 to 57 of 75

< previous next >

Publication Year	Title	Author(s), Editor(s), Other Contributor(s)	Publication Type
2007	An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy	*ZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED*	Articles in Journals
2009	In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapy	*BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS Christos*	Contributions to Conferences
2012	In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapy	*GRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias*	Contributions to Conferences
2009	Intravesical a-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice	*PFOST Birgit; SEIDI Christof; AUTENRIETH Michael; SAUR Dieter; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SCHWAIGER Markus; SENEKOWITSCH-SCHMIDTKE Reingard*	Articles in Journals
2010	Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230U	*MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred*	Articles in Journals
2010	Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†	*MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred*	Articles in Journals
2013	Measurement and modelling of the cross sections for the reaction 230Th(3He,3n)230U	*MORGENSTERN Alfred; ABBAS Kamel; SIMONELLI Federica; CAPOTE NOY R.; SIN M.; ZIELINSKA B.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos*	Articles in Journals
2012	Measurement of the 225Ac half-life	*POMME Stefaan; MAROULI MARIA; SULIMAN GABRIEL; DIKMEN HASAN; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN A.; STROH HEIKO; PAEPEN Jan; BRUCHERTSEIFER Frank, et al*	Articles in Journals
2012	Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostate	*RIZVI S.m.a.; ALLEN B.j.; LEE C.s.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; APOSTOLIDIS Christos; CLARKE R.a.*	Articles in Journals
2012	Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility study	*THIJSEN L.; SCHAART D.r.; DE VRIES D.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DENKOVA A.g.*	Articles in Journals
2008	Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231Pa	*MORGENSTERN Alfred; LEBEDA O.; STURSA J.; BRUCHERTSEIFER Frank; CAPOTE R.; MCGINLEY John; RASMUSSEN Gert; SIN M.; ZIELINSKA B.; APOSTOLIDIS Christos*	Articles in Journals
2008	Production of Alpha Emitters for Targeted Alpha Therapy	*MORGENSTERN Alfred; ABBAS Kamel; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos*	Articles in Journals
2008	Production of Alpha Emitting Radionuclides for Nuclear Medicine	*MORGENSTERN Alfred; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank*	Articles in books
2008	Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformans	*BRYAN R. A.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.*	Articles in Journals
2009	Radioimmunotherapy Is Effective Against High-Inoculum Cryptococcus Neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal Cells	*BRYAN R. A.; JIANG Z.; HUANG X.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SELLERS R.; CASADEVALL A.; DADACHOVA E.*	Articles in Journals
2010	Radioimmunotherapy is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection	*BRYAN R. A.; JIANG Z.; HOWELL Roberta; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CASADEVALL A.; DADACHOVA E.*	Articles in Journals
2013	Radioimmunotherapy of Cryptococcus neoformans Spares Bystander Mammalian Cells	*BRYAN R. A.; JIANG Z.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; Casadevall Arturo; DADACHOVA E.*	Articles in Journals
2009	Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb	*PFOST B.; MORGENSTERN Alfred; SEIDL C.; BRUCHERTSEIFER Frank; AUTENRIETH M.; APOSTOLIDIS Christos; ABBAS Kamel; SENEKOWITSCH-SCHMIDTKE R.*	Contributions to Conferences
2012	Radioimmunotherapy of pancreatic cancer with 213Bi-labeled antibodies to intranuclear histones	*DADACHOVA E.; BRYAN R. A.; JIANG Z.; JANDL T; STRAUSS J; KOBA W; SELLERS R.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; EPSTEIN A*	Contributions to Conferences
2009	Radiolabeled Antibodies to Bacillus Anthracis Toxins are Bactericidal and Partially Therapeutic in Experimental Murine Anthrax	*RIVERA J.; NAKOUZI A.s.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DADACHOVA E.*	Articles in Journals

Showing results 38 to 57 of 75

< previous next >

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.

Top